BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20150804)

  • 1. Iatrogenic botulism after botulinum toxin type A injections.
    Coban A; Matur Z; Hanagasi HA; Parman Y
    Clin Neuropharmacol; 2010 May; 33(3):158-60. PubMed ID: 20150804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose standardization of botulinum toxin.
    Van den Bergh PY; Lison DF
    Adv Neurol; 1998; 78():231-5. PubMed ID: 9750920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines for the treatment of child spasticity using botulinum toxin].
    Pascual-Pascual SI; Herrera-Galante A; Póo P; García-Aymerich V; Aguilar-Barberà M; Bori-Fortuny I; García-Ruiz PJ; Garreta-Figuera R; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Vivancos-Matellano F;
    Rev Neurol; 2007 Mar 1-15; 44(5):303-9. PubMed ID: 17342682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulism-like syndrome after injections of botulinum toxin.
    Cobb DB; Watson WA; Fernandez MC
    Vet Hum Toxicol; 2000 Jun; 42(3):163. PubMed ID: 10839321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient.
    Crowner BE; Brunstrom JE; Racette BA
    Clin Neuropharmacol; 2007; 30(5):310-3. PubMed ID: 17909312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic botulism in an amateur weight-lifter.
    Duffey P; Brown C
    Mov Disord; 2006 Jul; 21(7):1056. PubMed ID: 16639740
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
    Ziak P
    Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin useful against writer's cramp].
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    Ned Tijdschr Geneeskd; 2009 Jan; 153(4):118-23. PubMed ID: 19348131
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of therapeutic botulinum toxin preparations.
    Dressler D; Benecke R
    Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrotising fasciitis as a complication of botulinum toxin injection.
    Latimer PR; Hodgkins PR; Vakalis AN; Butler RE; Evans AR; Zaki GA
    Eye (Lond); 1998; 12 ( Pt 1)():51-3. PubMed ID: 9614517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin: from drug to poison].
    Dressler D; Saberi FA
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S49-54. PubMed ID: 19685394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum toxin Type A. Indications and results].
    Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
    Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum treatment for post-stroke spasticity: low dose regime.
    Viriyavejakul A; Vachalathiti R; Poungvarin N
    J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.